Global Companion Animal Vaccines Market Growth 2025-2031
Description
The global Companion Animal Vaccines market size is predicted to grow from US$ 17890 million in 2025 to US$ 25250 million in 2031; it is expected to grow at a CAGR of 5.9% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
In this report, we study the Veterinary Products for Companion Animals mainly medicines, vaccines and others.
Some of the most popular companion animals are likely dogs and cats; other animals commonly kept may include pigs, red foxes, ferrets, and rabbits; rodents such as gerbils, hamsters, chinchillas, fancy rats, and guinea pigs; avian pets, such as canaries, parrots, and fowl; reptile pets, such as turtles, lizards and snakes; aquatic pets, such as fish, freshwater and saltwater aquatic snails, frogs; arthropod pets, such as tarantulas and hermit crabs, and many other species.
Companion animals (dogs, cats, and horses) have come to play an important part in the lives of many people. They provide companionship and a sense of responsibility, demand care and attention, and respond with affection.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 275%.
LP Information, Inc. (LPI) ' newest research report, the “Companion Animal Vaccines Industry Forecast” looks at past sales and reviews total world Companion Animal Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Companion Animal Vaccines sales for 2025 through 2031. With Companion Animal Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Companion Animal Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Companion Animal Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Companion Animal Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Companion Animal Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Companion Animal Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Companion Animal Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Companion Animal Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Segmentation by Application:
Canine
Avian
Feline
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bayer
Vetoquinol
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck
Merial
Key Questions Addressed in this Report
What is the 10-year outlook for the global Companion Animal Vaccines market?
What factors are driving Companion Animal Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Companion Animal Vaccines market opportunities vary by end market size?
How does Companion Animal Vaccines break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
In this report, we study the Veterinary Products for Companion Animals mainly medicines, vaccines and others.
Some of the most popular companion animals are likely dogs and cats; other animals commonly kept may include pigs, red foxes, ferrets, and rabbits; rodents such as gerbils, hamsters, chinchillas, fancy rats, and guinea pigs; avian pets, such as canaries, parrots, and fowl; reptile pets, such as turtles, lizards and snakes; aquatic pets, such as fish, freshwater and saltwater aquatic snails, frogs; arthropod pets, such as tarantulas and hermit crabs, and many other species.
Companion animals (dogs, cats, and horses) have come to play an important part in the lives of many people. They provide companionship and a sense of responsibility, demand care and attention, and respond with affection.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 275%.
LP Information, Inc. (LPI) ' newest research report, the “Companion Animal Vaccines Industry Forecast” looks at past sales and reviews total world Companion Animal Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Companion Animal Vaccines sales for 2025 through 2031. With Companion Animal Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Companion Animal Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Companion Animal Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Companion Animal Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Companion Animal Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Companion Animal Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Companion Animal Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Companion Animal Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Segmentation by Application:
Canine
Avian
Feline
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bayer
Vetoquinol
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck
Merial
Key Questions Addressed in this Report
What is the 10-year outlook for the global Companion Animal Vaccines market?
What factors are driving Companion Animal Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Companion Animal Vaccines market opportunities vary by end market size?
How does Companion Animal Vaccines break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
94 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Companion Animal Vaccines by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Companion Animal Vaccines by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
